15 surgeons from 13 different countries have undertaken 13 mixed reality orthopedic operations as part of a 24-hour event. The surgeons virtually collaborated using Microsoft HoloLens 2 and Dynamics 365 Remote Assist, and were led by Professor Thomas Grégory of the Avicenne AP-HP Hospital, France.

Medicine’s (virtual) world tour

Professor Grégory and his team led all 13 mixed reality surgeries from the Avicenne AP-HP Hospital. From there, the surgery toured a number of countries, including: France, India, UAE, South Africa, Ukraine, Germany, Belgium, Morocco, Brazil, Bolivia, Mexico, USA, UK.

Strengthening its preferred supplier position in the cruise segment, ABB will equip five newbuild vessels with Azipod® electric propulsion, which has a proven ability to significantly reduce fuel consumption on board.

Skeleton Technologies – a Global Cleantech 100 company and the largest European manufacturer of ultracapacitor-based energy storage – announced today it has completed a €41.3 million financing round. All existing investors participated in the equity raise and were joined by notable European entrepreneurs and international investors. 

As part of Singapore’s efforts to enhance its nation-wide COVID-19 testing capabilities, ABB’s high-precision robots have been deployed in a new automated laboratory system, known as the Rapid Automated Volume Enhancer (RAVE).

The system automates some of the manual steps usually required in sample processing. Two sets of RAVE and associated equipment can process an industry-topping throughput of close to 4,000 samples a day. RAVE also reduces test contamination and infection risks for laboratory workers.

Using approximately 2.6 million microscopy images of canine kidney cells, members of an international research group, containing contributors from Estonia and Russia have built and trained a deep learning model to better understand how cells grow and divide. This research opens a novel way to identify more quickly and more easily the cell cycle ‘clock’ for every cell that is essential to understand diseases like cancer. The methods and results of their work have now been published in the journal Molecular Systems Biology.

ABB will supply an integrated power system package that will ensure the world’s largest and most technologically advanced diamond recovery vessel meets exceptional safety, efficiency and availability requirements. The vessel is being built by Damen at Damen Shipyards Mangalia on the Black Sea in Romania. Financial details of the order were not disclosed.

89 startups from across Europe of which 14 are based in Scandinavia are selected for support to accelerate the development of promising health solutions.

Headstart is set up to help startups getting closer to market, receive clinical verification, evaluate patient need and benefit of their product or service as well as attracting further private investment. Through EIT Health’s network, the companies will make valuable contacts within EIT Health’s innovation ecosystem and will receive financial support of up to €50 000 each.

Recipo launched Recipo Material, a purpose-built recycling plant for plastic from electronic waste in Riga, Latvia. In association with their members, Recipo continues to set an example by providing a viable European recycling solution for plastic. As the leading Producer Responsibility Partner for electronics in the Nordic region, Recipo is the first collection scheme in the world to pioneer their own recycling plant.

Three leading European Air Forces have deployed single patient isolation pods to rescue covid-19 patients from remote areas. In record time, the EpiShuttle is now in service with The British Royal Air Force, The Royal Norwegian Air Force, the Royal Danish Air Force and the German Air Ambulance DRF.

The use of single patient isolation systems increase the efficiency of our healthcare system during the pandemic outbreak.

An ambulance or aircraft would normally require 2-4 hours of disinfection between every transport. Isolation pods reduce the need for disinfecting the ambulance, protecting both the crew and the next patient from being infected, says CEO of EpiGuard, Ellen Cathrine Andersen.

The biopharma company Medicago successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease.

Medicago, a biopharmaceutical company headquartered in Quebec City, announced today that they have successfully produced a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 (virus causing the COVID-19 disease) gene.